Quanterix Corporation
Quanterix Corporation is engaged in developing a platform for single molecule analysis. The company offers SiMoA technology that are used by physicians, drug developers and researchers to detect and quantify proteins present in blood and other body fluids at very low and previously undetectable concentrations. Its technology is also used to determine the variation in kinetics among populations of individual enzyme molecules and their interaction partners. In 2007 the company changed its name from Digital Genomics, Inc. to Quanterix Corporation. The company is headquartered in Cambridge, Massachusetts.
Street:
One Kendall Square
City:
Cambridge
Postcode:
02139
Federal State :
United States
WebSite:
www.quanterix.com
Fax:
1-617-3019401
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

